Literature DB >> 4319967

Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.

J O Harris, E W Swenson, J E Johnson.   

Abstract

Phagocytic ability, glucose utilization, and ultrastructural morphology were studied in human alveolar macrophages in smokers and nonsmokers. The macrophages were obtained by bronchopulmonary lavage and the studies were carried out in vitro in the absence of smoke. Phagocytic ability was measured as the decrease in the number of viable Staphylococcus albus organisms incubated with the macrophages. Measurements of (14)CO(2) formation from glucose-U-(14)C were made in a resting state. 90-95% of the cells obtained by lavage were large mononuclear macrophages of which approximately 90% remained viable at the end of the experiment. Smokers yielded many more macrophages per lavage (mean 46.4 x 10(6) +/-7.4) compared to the nonsmokers (mean 10.2 x 10(6) +/-2.3). The decline in viable organisms was the same in each group, indicating phagocytic competence of alveolar macrophages removed from smokers. However, the mean glucose utilization for the smokers was 4.3 +/-0.2 mmumoles/10(6) cells and 1.4 +/-0.7 mmumoles/10(6) cells for the nonsmokers. This very significant difference (P < 0.0001) suggests that smokers' macrophages have a higher resting energy requirement than those of nonsmokers. Comparison of the ultrastructural morphology of the alveolar macrophages from each group reveals that the cells from smokers differ from those of nonsmokers in that they are slightly larger, and contain more golgi vesicles, endoplasmic reticulum, and residual bodies. The residual bodies in smokers' cells contain distinctive fiber-like inclusions.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4319967      PMCID: PMC535784          DOI: 10.1172/JCI106426

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Determination of cell viability.

Authors:  J H HANKS; J H WALLACE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

Review 2.  The chemical composition of tobacco and tobacco smoke.

Authors:  R L Stedman
Journal:  Chem Rev       Date:  1968-04       Impact factor: 60.622

Review 3.  The role of lysosomes in inflammation and disease.

Authors:  G Weissmann
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

4.  A comparison of alveolar macrophages and pulmonary surfactant(?) obtained from the lungs of human smokers and nonsmokers by endobronchial lavage.

Authors:  S A Pratt; T N Finley; M H Smith; A J Ladman
Journal:  Anat Rec       Date:  1969-04

5.  Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease.

Authors:  T N Finley; E W Swenson; W S Curran; G L Huber; A J Ladman
Journal:  Ann Intern Med       Date:  1967-04       Impact factor: 25.391

6.  Mechanisms of antibacterial action in the respiratory system.

Authors:  E H Kass; G M Green; E Goldstein
Journal:  Bacteriol Rev       Date:  1966-09

7.  A possible experimental approach to the association of hereditary alpha-1-antitrypsin deficiency and pulmonary emphysema.

Authors:  F Kueppers; A G Bearn
Journal:  Proc Soc Exp Biol Med       Date:  1966-04

8.  Metabolic and immunologic activities of alveolar macrophages.

Authors:  Q N Myrvik; D G Evans
Journal:  Arch Environ Health       Date:  1967-01

9.  The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages.

Authors:  G M Green; D Carolin
Journal:  N Engl J Med       Date:  1967-02-23       Impact factor: 91.245

10.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  65 in total

1.  Comparison of leukocyte count and function in smoking and nonsmoking young men.

Authors:  R C Noble; B B Penny
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  Alveolar lavage cytology as a method for diagnosis of early rejection of transplanted lungs.

Authors:  S Blümcke; U Achterrath; F J Veith
Journal:  Pneumonologie       Date:  1975-09-26

3.  Immunocompetent cells from the lower respiratory tract of normal human lungs.

Authors:  R P Daniele; M D Altose; D T Rowlands
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

4.  Intra-alveolar macrophage numbers in current smokers and non-smokers: a morphometric study of tissue sections.

Authors:  W A Wallace; M Gillooly; D Lamb
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

5.  Effect of tobacco smoking on the functions of polymorphonuclear leukocytes.

Authors:  J Corberand; F Nguyen; A H Do; G Dutau; P Laharrague; A M Fontanilles; B Gleizes
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines.

Authors:  J S MacKenzie; I H MacKenzie; P G Holt
Journal:  J Hyg (Lond)       Date:  1976-12

7.  Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers.

Authors:  Navneet K Dhillon; William J Murphy; Michael B Filla; Ana J Crespo; Heath A Latham; Amy O'Brien-Ladner
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-06       Impact factor: 4.219

8.  Effect of ionizing radiation on prostaglandin-like activity in tissues.

Authors:  V Eisen; D I Walker
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

9.  Ultrastructural alterations in canine lung allografts.

Authors:  B Gondos; P White; J R Benfield
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

10.  Surface morphology and function of human pulmonary alveolar macrophages from smokers and non-smokers.

Authors:  M Ando; M Sugimoto; R Nishi; M Suga; S Horio; H Kohrogi; K Shimazu; S Araki
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.